How cost-effective are new cancer drugs in the U.S.?
نویسندگان
چکیده
منابع مشابه
Cost-effectiveness of hypothetical new cancer drugs
Background: In the last decade, a number of new treatment modalities have been developed for patients with small cell lung cancer (SCLC). The clinical effects are encouraging, but little is known about the costs and cost-effectiveness of new drugs. Methods: A Markov chain model has been developed to project patient outcomes and costs for patients with advanced SCLC. All patients in the control ...
متن کاملThe cost and value of cancer drugs – are new innovations outpacing our ability to pay?
Cancer drug expenditures have been increasing significantly in countries around the world. A recent paper in the IJHPR provides new knowledge and insights into this global phenomenon by analyzing how it is playing out in an Israeli health plan with over two million members, whose state-of-the-art information systems provide an opportunity to explore these changes in a comprehensive, detailed an...
متن کاملCost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
BACKGROUND In recent years, the increased efficacy and effectiveness of antiretroviral treatment has led to longer survival of patients infected with human immunodeficiency virus (HIV), but has also raised the question of what happens to consumption of resources. Early highly active antiretroviral treatment (HAART), management of hepatitis C virus (HCV) coinfection, and expensive newly marketed...
متن کاملThe days of cost effective management for nephrolithiasis are already upon us
Transl Androl Urol 2014;3(3):284 www.amepc.org/tau Nephrolithiasis prevalence rates continue to rise globally and have nearly doubled within the United States over the last few decades. At the same time, health care costs have risen within the United States at an alarming rate. The economic burden of nephrolithiasis is estimated at greater than $5 billion annually. This estimate is based on dir...
متن کاملHow safe are new drugs? Market withdrawal of drugs approved in Canada between 1990 and 2009
BACKGROUND Studying drugs withdrawn from the market for safety reasons can help in evaluating the strengths and weaknesses of the pre- and post-market safety evaluation systems. This study considered 2 questions: Has there been a change over time in the percentage of new drugs that are eventually withdrawn because of safety reasons? How long are new drugs on the market before their serious safe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Pharmacoeconomics & Outcomes Research
سال: 2020
ISSN: 1473-7167,1744-8379
DOI: 10.1080/14737167.2020.1709965